216 related articles for article (PubMed ID: 22503909)
1. Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
Haynes CA; De Jesús VR
Clin Chim Acta; 2012 Aug; 413(15-16):1217-21. PubMed ID: 22503909
[TBL] [Abstract][Full Text] [Related]
2. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
[TBL] [Abstract][Full Text] [Related]
3. Flow injection ionization-tandem mass spectrometry-based estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat MD; Chandra SR
Clin Chim Acta; 2019 Aug; 495():167-173. PubMed ID: 30980791
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
[TBL] [Abstract][Full Text] [Related]
6. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy.
Huffnagel IC; van de Beek MC; Showers AL; Orsini JJ; Klouwer FCC; Dijkstra IME; Schielen PC; van Lenthe H; Wanders RJA; Vaz FM; Morrissey MA; Engelen M; Kemp S
Mol Genet Metab; 2017 Dec; 122(4):209-215. PubMed ID: 29089175
[TBL] [Abstract][Full Text] [Related]
7. Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.
Sandlers Y; Moser AB; Hubbard WC; Kratz LE; Jones RO; Raymond GV
Mol Genet Metab; 2012 Mar; 105(3):416-20. PubMed ID: 22197596
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
[TBL] [Abstract][Full Text] [Related]
9. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
[TBL] [Abstract][Full Text] [Related]
10. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
Wang Y; Tian G; Ji W; Wang S; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
[TBL] [Abstract][Full Text] [Related]
11. Newborn Screen for X-Linked Adrenoleukodystrophy Using Flow Injection Tandem Mass Spectrometry in Negative Ion Mode.
Teber TA; Conti BJ; Haynes CA; Hietala A; Baker MW
Int J Neonatal Screen; 2022 Apr; 8(2):. PubMed ID: 35466198
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders.
Jaspers YRJ; Ferdinandusse S; Dijkstra IME; Barendsen RW; van Lenthe H; Kulik W; Engelen M; Goorden SMI; Vaz FM; Kemp S
Front Cell Dev Biol; 2020; 8():690. PubMed ID: 32903870
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific newborn screening for X-linked adrenoleukodystrophy.
Albersen M; van der Beek SL; Dijkstra IME; Alders M; Barendsen RW; Bliek J; Boelen A; Ebberink MS; Ferdinandusse S; Goorden SMI; Heijboer AC; Jansen M; Jaspers YRJ; Metgod I; Salomons GS; Vaz FM; Verschoof-Puite RK; Visser WF; Dekkers E; Engelen M; Kemp S
J Inherit Metab Dis; 2023 Jan; 46(1):116-128. PubMed ID: 36256460
[TBL] [Abstract][Full Text] [Related]
14. Aicardi-Goutières syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy.
Tise CG; Morales JA; Lee AS; Velez-Bartolomei F; Floyd BJ; Levy RJ; Cusmano-Ozog KP; Feigenbaum AS; Ruzhnikov MRZ; Lee CU; Enns GM
Am J Med Genet A; 2021 Jun; 185(6):1848-1853. PubMed ID: 33683010
[TBL] [Abstract][Full Text] [Related]
15. Utility of measuring very long-chain fatty-acyl carnitines in dried blood spots for newborn screening of X-linked Adrenoleukodystrophy.
Natarajan A; Christopher R; Palakuzhiyil SV; Chandra SR
Mol Genet Metab Rep; 2021 Mar; 26():100720. PubMed ID: 33552912
[TBL] [Abstract][Full Text] [Related]
16. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of X-Linked Adrenoleukodystrophy Newborn Screening in North Carolina.
Lee S; Clinard K; Young SP; Rehder CW; Fan Z; Calikoglu AS; Bali DS; Bailey DB; Gehtland LM; Millington DS; Patel HS; Beckloff SE; Zimmerman SJ; Powell CM; Taylor JL
JAMA Netw Open; 2020 Jan; 3(1):e1920356. PubMed ID: 32003821
[TBL] [Abstract][Full Text] [Related]
18. Development, validation, and clinical application of an FIA-MS/MS method for the quantification of lysophosphatidylcholines in dried blood spots.
Yue X; Liu W; Liu Y; Shen M; Zhai Y; Ma Z; Cao Z
J Clin Lab Anal; 2022 Jan; 36(1):e24099. PubMed ID: 34788474
[TBL] [Abstract][Full Text] [Related]
19. High incidence of null variants identified from newborn screening of X-linked adrenoleukodystrophy in Taiwan.
Chen HA; Hsu RH; Chen PW; Lee NC; Chiu PC; Hwu WL; Chien YH
Mol Genet Metab Rep; 2022 Sep; 32():100902. PubMed ID: 36046390
[TBL] [Abstract][Full Text] [Related]
20. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings.
Hubbard WC; Moser AB; Tortorelli S; Liu A; Jones D; Moser H
Mol Genet Metab; 2006; 89(1-2):185-7. PubMed ID: 16828324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
